74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Rockwell Medical Inc
Closed
SectorHealthcare
1.03
Overview
Share price change
24h
Min
1
Max
1.03
Income | -261K -1.8M |
|---|---|
Sales | -144K 16M |
EPS | -0.05 |
Profit margin | -11.006 |
Employees | 244 |
Recommendations | Buy |
|---|---|
12 Months Forecast | +257.14% upside |
Next Earnings | 26 Mar 2026 |
|---|
Market Cap | -4.6M 30M |
|---|---|
Previous open | 1.03 |
Previous close | 1.03 |
News Sentiment
By Acuity
50%
50%
147 / 350 Healthcare
Rockwell Medical Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Rockwell Medical Inc Forecast
Price Target
By TipRanks
257.14% upside
12 Months Forecast
Average 3.75 USD 257.14%
High 5 USD
Low 2.5 USD
Based on 2 Wall Street analysts offering 12 month price targets forRockwell Medical Inc - Dist in the last 3 months.
Sentiment
By Acuity
147 / 350 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
Operating profit
$
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Live chat